U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1586+5G>A AND Homozygous familial hypercholesterolemia

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 26, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004017559.1

Allele description [Variation Report for NM_000527.5(LDLR):c.1586+5G>A]

NM_000527.5(LDLR):c.1586+5G>A

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1586+5G>A
HGVS:
  • NC_000019.10:g.11113767G>A
  • NG_009060.1:g.29387G>A
  • NM_000527.5:c.1586+5G>AMANE SELECT
  • NM_001195798.2:c.1586+5G>A
  • NM_001195799.2:c.1463+5G>A
  • NM_001195800.2:c.1082+5G>A
  • NM_001195803.2:c.1205+5G>A
  • LRG_274t1:c.1586+5G>A
  • LRG_274:g.29387G>A
  • NC_000019.9:g.11224443G>A
  • NM_000527.4:c.1586+5G>A
  • c.1586+5G>A
Links:
LDLR-LOVD, British Heart Foundation: LDLR_001463; dbSNP: rs781362878
NCBI 1000 Genomes Browser:
rs781362878
Molecular consequence:
  • NM_000527.5:c.1586+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195798.2:c.1586+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195799.2:c.1463+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195800.2:c.1082+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195803.2:c.1205+5G>A - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Homozygous familial hypercholesterolemia
Synonyms:
Familial hypercholesterolemia - homozygous
Identifiers:
MONDO: MONDO:0018328; MedGen: C0342881

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004848107Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely Pathogenic
(Aug 26, 2022)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Familial Hypercholesterolemia in Greek children and their families: genotype-to-phenotype correlations and a reconsideration of LDLR mutation spectrum.

Mollaki V, Progias P, Drogari E.

Atherosclerosis. 2014 Dec;237(2):798-804. doi: 10.1016/j.atherosclerosis.2014.09.031. Epub 2014 Oct 30.

PubMed [citation]
PMID:
25463123

Multiplex ARMS analysis to detect 13 common mutations in familial hypercholesterolaemia.

Taylor A, Tabrah S, Wang D, Sozen M, Duxbury N, Whittall R, Humphries SE, Norbury G.

Clin Genet. 2007 Jun;71(6):561-8.

PubMed [citation]
PMID:
17539906
See all PubMed Citations (7)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV004848107.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

The c.1586+5G>A variant in LDLR has been reported in 7 individuals with familial hypercholesterolemia (FH) and segregated with disease in at least 7 affected relatives from 2 families (Ekstrom 1995, Jensen 1999, Fouchier 2005, Taylor 2007, Guardamagna 2009, Mollaki 2014). Additionally, this variant has been identified in 6/30752 South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/) and is present in ClinVar (Variation ID: 251909). Please note that for diseases with clinical variability, reduced penetrance, or recessive inheritance, pathogenic variants may be present at a low frequency in the general population. In vitro functional studies provide some evidence that the c.1586+5G>A variant may impact protein function (Jensen 1999. This variant is located in the 5' splice region. Computational tools do suggest an impact to splicing. In summary, although additional studies are required to fully establish its clinical significance, the c.1586+5G>A variant is likely pathogenic for FH in an autosomal dominant manner based on cased observations, segregation studies, functional and computational evidence. The ACMG/AMP Criteria applied: PP1_Strong, PS4_Moderate, PP3, PS3_Supporting.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024